SpartanNash Company (NASDAQ:SPTN) Stock Position Raised by Legato Capital Management LLC

Legato Capital Management LLC grew its position in SpartanNash Company (NASDAQ:SPTN - Free Report) by 204.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 54,036 shares of the company's stock after purchasing an additional 36,265 shares during the period. Legato Capital Management LLC owned approximately 0.16% of SpartanNash worth $1,095,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State of Wyoming bought a new position in shares of SpartanNash in the fourth quarter valued at approximately $43,000. Tower Research Capital LLC TRC boosted its holdings in shares of SpartanNash by 167.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,966 shares of the company's stock valued at $109,000 after acquiring an additional 3,735 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in shares of SpartanNash in the fourth quarter valued at approximately $113,000. KLP Kapitalforvaltning AS bought a new position in shares of SpartanNash in the fourth quarter valued at approximately $132,000. Finally, GAMMA Investing LLC boosted its holdings in shares of SpartanNash by 8.5% in the first quarter. GAMMA Investing LLC now owns 8,097 shares of the company's stock valued at $164,000 after acquiring an additional 636 shares in the last quarter. Institutional investors own 84.59% of the company's stock.

SpartanNash Price Performance

SPTN stock traded down $0.04 on Friday, hitting $26.54. 915,179 shares of the company's stock traded hands, compared to its average volume of 785,111. SpartanNash Company has a 1-year low of $17.30 and a 1-year high of $26.69. The stock has a market cap of $898.38 million, a price-to-earnings ratio of -82.94 and a beta of 0.44. The stock has a fifty day moving average of $22.66 and a 200-day moving average of $20.53. The company has a current ratio of 1.66, a quick ratio of 0.86 and a debt-to-equity ratio of 1.03.

SpartanNash (NASDAQ:SPTN - Get Free Report) last released its earnings results on Thursday, May 29th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.08). SpartanNash had a negative net margin of 0.11% and a positive return on equity of 8.26%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same period in the prior year, the company earned $0.53 earnings per share. The firm's revenue for the quarter was up 3.7% on a year-over-year basis. On average, analysts forecast that SpartanNash Company will post 1.79 EPS for the current fiscal year.

SpartanNash Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Friday, June 13th were given a $0.22 dividend. The ex-dividend date of this dividend was Friday, June 13th. This represents a $0.88 annualized dividend and a dividend yield of 3.32%. SpartanNash's dividend payout ratio (DPR) is presently -275.00%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on SPTN shares. Wall Street Zen cut shares of SpartanNash from a "buy" rating to a "hold" rating in a report on Friday, May 30th. BMO Capital Markets reiterated a "market perform" rating and issued a $26.90 price objective (up from $20.00) on shares of SpartanNash in a report on Tuesday, June 24th.

SpartanNash Profile

SpartanNash Company distributes and retails grocery products in the United States of America. It operates through Wholesale and Retail segments. The Wholesale segment offers grocery products and perishable food products, including dry groceries, produce, dairy products, meat, delicatessen items, bakery goods, frozen food, seafood, floral products, general merchandise, beverages, tobacco products, health and beauty care, and pharmaceutical products to independent retailers, national accounts, food service distributors, e-commerce providers, and corporate owned retail stores.